Conference Day 2
Wednesday, May 4th, 2022
• Overview of the drug development cycle, the regulatory pathway and the different IP strategies to protect
• Specific focus on the legal frame works for Supplementary Protection Certificates and different forms of
data/market exclusivity in Europe.
• Update on recent developments, specifically, the SPC manufacturing waiver.